Category: Life Sciences
Global Life Sciences
-
Nanobiotechnology
... of 7.0% over the analysis period 2023-2030. Pharmaceuticals & Biotechnology End-Use Industry, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of ... Read More
-
Hospital Information Systems (HIS)
... reach US$116.2 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. HIS Software, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More
-
Contact Lens Solutions
... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Multi Purpose Contact Lens Solutions, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach ... Read More
-
Laboratory Refrigerators and Ovens
... reach US$2.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. General Purpose Laboratory Refrigerators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR ... Read More
-
Advanced Wound Care Products
... reach US$18.1 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Moist Wound Dressings, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and ... Read More
-
DNA Sequencing
... at a CAGR of 11.8% over the analysis period 2023-2030. DNA Sequencing Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end ... Read More
-
Drug-Eluting Stents
... at a CAGR of 5.9% over the analysis period 2023-2030. Polymer-Free Drug-Eluting Stents, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$7.9 Billion by the end ... Read More
-
Ophthalmic Pharmaceutical Drugs
... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Anti-VEGF Agents Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$34.3 ... Read More
-
Pharmaceutical Contract Manufacturing
... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. API/Bulk Drugs, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$94.8 Billion by ... Read More
-
Medical Waste Management
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Collection, Transportation & Storage Services, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach ... Read More
-
Electronic Data Capture
... by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Electronic Data Capture Services, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$1.4 ... Read More
-
Medical Thermometers
... at a CAGR of 6.8% over the analysis period 2023-2030. Digital Thermometers, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Pipettes and Pipettors
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Pipette Tips, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by ... Read More
-
Cardiology IT Workflow Solutions
... reach US$1.8 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More
-
Traditional Wound Management Products
... reach US$7.7 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Gauzes, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$4.0 ... Read More
-
Drug Discovery Technologies
... by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. Small Molecule Drugs Discovery Technologies, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach ... Read More
-
Organ and Tissue Transplantation
... reach US$37.2 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2023-2030. Tissue Products, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach ... Read More
-
Cardiac Biomarkers
... at a CAGR of 7.4% over the analysis period 2023-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$11.2 Billion by the ... Read More
-
Specialty Enzymes
... at a CAGR of 4.1% over the analysis period 2023-2030. Protease, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$2.1 Billion by the end of the ... Read More
-
Titrators (Automatic and Manual)
... reach US$548.4 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Coulometric Titrators, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach ... Read More
-
Clinical Laboratory Services
... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Clinical Chemistry, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$163.3 Billion by ... Read More
-
Wireless Health and Fitness Devices
... year 2023, is expected to reach 918.0 Million Units by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. Monitoring Application, one of the segments analyzed in the report, is expected to ... Read More
-
Healthcare IT
... at a CAGR of 15.8% over the analysis period 2023-2030. Healthcare IT Services, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$547.7 Billion by the end ... Read More
-
Biopharmaceutical Bioseparation Systems
... by 2030, growing at a CAGR of 11.0% over the analysis period 2023-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$15.8 Billion by ... Read More
-
Orthodontic Supplies
... at a CAGR of 10.6% over the analysis period 2023-2030. Fixed Braces, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.6 Billion by the end of ... Read More